![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Department of Clinical Biochemistry, Rigshospitalet, 2100 Copenhagen, Denmark;
* Experimental Cardiovascular Research, Department of Medicine, Lund University, UMAS, 205 02 Malmö, Sweden; and
Institute of Plant Biology, Department of Plant Biochemistry, Royal Veterinary and Agricultural College, 1871 Frederiksberg, Denmark
3To whom correspondence should be addressed. E-mail: Silvio.Zaina{at}rh.dk.
Methylation is a reversible modification of DNA participating in epigenetic regulation of gene expression. It is now clear that atherosclerosis is associated with aberrant DNA methylation patterns in the vascular tissue and peripheral blood cells, but the origin of this anomaly is poorly understood. Based on evidence that global DNA hypomethylation coexists with hyperhomocysteinemia in advanced human atherosclerosis, it is widely assumed that altered DNA methylation patterns in atherosclerosis are mainly secondary to a decrease in factors essential for the synthesis of S-adenosyl methionine (SAM, the main methyl group donor in DNA methylation reactions), such as folate and vitamin B-12, or to homocysteine-induced blocking of SAM biosynthesis. Nonetheless, recent work expanded this view by showing that both local DNA hyper- and hypomethylation occur in early atherosclerosis in normohomocysteinemic mice and that atherogenic lipoprotein profiles promote DNA hypermethylation in cultured human macrophages. These findings suggest that during early atherosclerosis, nutritional factors affect DNA methylation patterns by mechanisms that are likely to be independent of vitamin or homocysteine levels. These data have the potential to assist in the identification of preventive or therapeutic avenues for cardiovascular disease.
KEY WORDS: • DNA methylation • homocysteine • atherosclerosis
This article has been cited by other articles:
|
|
 |
|
  S.P. Barros and S. Offenbacher Epigenetics: Connecting Environment and Genotype to Phenotype and Disease Journal of Dental Research, May 1, 2009; 88(5): 400 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. T. Aggarwal, S. L. Pfister, and W. B. Campbell Hypercholesterolemia Enhances 15-Lipoxygenase-Mediated Vasorelaxation and Acetylcholine-Induced Hypotension Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2209 - 2215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. T. Williams, T. A. Garrow, and K. L. Schalinske Type I Diabetes Leads to Tissue-Specific DNA Hypomethylation in Male Rats J. Nutr., November 1, 2008; 138(11): 2064 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Malanovic, I. Streith, H. Wolinski, G. Rechberger, S. D. Kohlwein, and O. Tehlivets S-Adenosyl-L-homocysteine Hydrolase, Key Enzyme of Methylation Metabolism, Regulates Phosphatidylcholine Synthesis and Triacylglycerol Homeostasis in Yeast: IMPLICATIONS FOR HOMOCYSTEINE AS A RISK FACTOR OF ATHEROSCLEROSIS J. Biol. Chem., August 29, 2008; 283(35): 23989 - 23999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Stenvinkel and T. J. Ekstrom Epigenetics--a helpful tool to better understand processes in clinical nephrology? Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1493 - 1496. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Agrawal, W.-K. Hofmann, N. Tidow, M. Ehrich, D. v. d. Boom, S. Koschmieder, W. E. Berdel, H. Serve, and C. Muller-Tidow The C/EBP{delta} tumor suppressor is silenced by hypermethylation in acute myeloid leukemia Blood, May 1, 2007; 109(9): 3895 - 3905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Herrmann, O. Taban-Shoma, U. Hubner, A. Pexa, H. Kilter, N. Umanskaya, R. Hans Straub, M. Bohm, and W. Herrmann Hyperhomocysteinemia and Myocardial Expression of Brain Natriuretic Peptide in Rats Clin. Chem., April 1, 2007; 53(4): 773 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Loscalzo Homocysteine Trials -- Clear Outcomes for Complex Reasons N. Engl. J. Med., April 13, 2006; 354(15): 1629 - 1632. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Rodenhiser and M. Mann Epigenetics and human disease: translating basic biology into clinical applications Can. Med. Assoc. J., January 31, 2006; 174(3): 341 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Ulrey, L. Liu, L. G. Andrews, and T. O. Tollefsbol The impact of metabolism on DNA methylation Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R139 - R147. [Abstract] [Full Text] [PDF]
|
|
